001     912542
005     20231027114348.0
024 7 _ |a 10.1007/s00415-022-11444-w
|2 doi
024 7 _ |a 0012-1037
|2 ISSN
024 7 _ |a 0340-5354
|2 ISSN
024 7 _ |a 0939-1517
|2 ISSN
024 7 _ |a 1432-1459
|2 ISSN
024 7 _ |a 1619-800X
|2 ISSN
024 7 _ |a 2128/34030
|2 Handle
024 7 _ |a 36422669
|2 pmid
024 7 _ |a WOS:000887862600002
|2 WOS
037 _ _ |a FZJ-2022-05715
082 _ _ |a 610
100 1 _ |a Schild, Ann-Katrin
|0 0000-0002-1920-0198
|b 0
|e Corresponding author
245 _ _ |a Multidomain cognitive impairment in non-hospitalized patients with the post-COVID-19 syndrome: results from a prospective monocentric cohort
260 _ _ |a Berlin
|c 2023
|b Springer
264 _ 1 |3 online
|2 Crossref
|b Springer Science and Business Media LLC
|c 2022-11-23
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1677563823_13022
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a BackgroundA fraction of patients with asymptomatic to mild/moderate acute COVID-19 disease report cognitive deficits as part of the post-COVID-19 syndrome. This study aimed to assess the neuropsychological profile of these patients.MethodsAssessment at baseline (three months or more following acute COVID-19) of a monocentric prospective cohort of patients with post-COVID-19 syndrome. Multidomain neuropsychological tests were performed, and questionnaires on depression, anxiety, fatigue, sleep, and general health status were administered.ResultsOf the 58 patients screened, six were excluded due to possible alternative causes of cognitive impairment (major depression, neurodegenerative disease). Of the remaining 52 individuals, only one had a below-threshold screening result on Mini-Mental State Examination, and 13 scored below the cut-off on Montreal Cognitive Assessment. Extended neuropsychological testing revealed a neurocognitive disorder (NCD) in 31 (59.6%) participants with minor NCD in the majority of cases (n = 26). In patients with NCD, the cognitive domains learning/memory and executive functions were impaired in 60.7%, complex attention in 51.6%, language in 35.5%, and perceptual-motor function in 29.0%. Cognitive profiles were associated with daytime sleepiness but not with depression, anxiety, sleep quality, total general health status, or fatigue.ConclusionNeurocognitive impairment can be confirmed in around 60% of individuals with self-reported deficits as part of post-COVID-19 syndrome following a mild acute COVID-19 disease course. Notably, screening tests cannot reliably detect this dysfunction. Standard psychiatric assessments showed no association with cognitive profiles. Longitudinal studies are needed to further evaluate the course of neurocognitive deficits and clarify pathophysiology.
536 _ _ |a 5251 - Multilevel Brain Organization and Variability (POF4-525)
|0 G:(DE-HGF)POF4-5251
|c POF4-525
|f POF IV
|x 0
542 _ _ |i 2022-11-23
|2 Crossref
|u https://creativecommons.org/licenses/by/4.0
542 _ _ |i 2022-11-23
|2 Crossref
|u https://creativecommons.org/licenses/by/4.0
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Goereci, Yasemin
|0 0000-0003-3330-8231
|b 1
|e Corresponding author
700 1 _ |a Scharfenberg, Daniel
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Klein, Kim
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Lülling, Joachim
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Meiberth, Dix
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Schweitzer, Finja
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Stürmer, Sophie
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Zeyen, Philip
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Sahin, Derya
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Fink, Gereon R.
|0 P:(DE-Juel1)131720
|b 10
|u fzj
700 1 _ |a Jessen, Frank
|0 P:(DE-HGF)0
|b 11
700 1 _ |a Franke, Christiana
|0 P:(DE-HGF)0
|b 12
700 1 _ |a Onur, Oezguer A.
|0 P:(DE-HGF)0
|b 13
700 1 _ |a Kessler, Josef
|0 P:(DE-HGF)0
|b 14
700 1 _ |a Warnke, Clemens
|0 P:(DE-HGF)0
|b 15
700 1 _ |a Maier, Franziska
|0 P:(DE-HGF)0
|b 16
773 1 8 |a 10.1007/s00415-022-11444-w
|b Springer Science and Business Media LLC
|d 2022-11-23
|3 journal-article
|2 Crossref
|t Journal of Neurology
|y 2022
|x 0340-5354
773 _ _ |a 10.1007/s00415-022-11444-w
|0 PERI:(DE-600)1421299-7
|p 1215-1223
|t Journal of neurology
|v 270
|y 2023
|x 0340-5354
856 4 _ |u https://juser.fz-juelich.de/record/912542/files/s00415-022-11444-w.pdf
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:912542
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 10
|6 P:(DE-Juel1)131720
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5251
|x 0
914 1 _ |y 2023
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-10-21
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-21
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J NEUROL : 2022
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-21
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-21
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b J NEUROL : 2022
|d 2023-10-21
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-3-20090406
|k INM-3
|l Kognitive Neurowissenschaften
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-3-20090406
980 1 _ |a FullTexts
999 C 5 |a 10.1038/s41598-021-95565-8
|1 S Lopez-Leon
|9 -- missing cx lookup --
|2 Crossref
|u Lopez-Leon S, Wegman-Ostrosky T, Perelman C et al (2021) More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. https://doi.org/10.1038/s41598-021-95565-8
|t Sci Rep
|y 2021
999 C 5 |a 10.1056/NEJMp2109285
|9 -- missing cx lookup --
|1 S Phillips
|p 577 -
|2 Crossref
|u Phillips S, Williams MA (2021) Confronting our next national health disaster—long-haul covid. N Engl J Med 385:577–579. https://doi.org/10.1056/NEJMp2109285
|t N Engl J Med
|v 385
|y 2021
999 C 5 |a 10.1001/jamanetworkopen.2021.0830
|1 JK Logue
|9 -- missing cx lookup --
|2 Crossref
|u Logue JK, Franko NM, McCulloch DJ et al (2021) Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open 4:e210830. https://doi.org/10.1001/jamanetworkopen.2021.0830
|t JAMA Netw Open
|v 4
|y 2021
999 C 5 |a 10.1038/s41591-021-01283-z
|9 -- missing cx lookup --
|1 A Nalbandian
|p 601 -
|2 Crossref
|u Nalbandian A, Sehgal K, Gupta A et al (2021) Post-acute COVID-19 syndrome. Nat Med 27:601–615. https://doi.org/10.1038/s41591-021-01283-z
|t Nat Med
|v 27
|y 2021
999 C 5 |a 10.1016/S2215-0366(20)30203-0
|9 -- missing cx lookup --
|1 JP Rogers
|p 611 -
|2 Crossref
|u Rogers JP, Chesney E, Oliver D et al (2020) Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry 7:611–627. https://doi.org/10.1016/S2215-0366(20)30203-0
|t Lancet Psychiatry
|v 7
|y 2020
999 C 5 |a 10.1038/s41386-021-00995-7
|9 -- missing cx lookup --
|1 KE Burdick
|p 2225 -
|2 Crossref
|u Burdick KE, Millett CE (2021) The impact of COVID-19 on cognition in severe cases highlights the need for comprehensive neuropsychological evaluations in all survivors. Neuropsychopharmacology 46:2225. https://doi.org/10.1038/s41386-021-00995-7
|t Neuropsychopharmacology
|v 46
|y 2021
999 C 5 |a 10.1186/s13195-020-00640-3
|9 -- missing cx lookup --
|1 MT Heneka
|p 69 -
|2 Crossref
|u Heneka MT, Golenbock D, Latz E et al (2020) Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther 12:69. https://doi.org/10.1186/s13195-020-00640-3
|t Alzheimers Res Ther
|v 12
|y 2020
999 C 5 |a 10.1038/s41386-021-00978-8
|9 -- missing cx lookup --
|1 A Jaywant
|p 2235 -
|2 Crossref
|u Jaywant A, Vanderlind WM, Alexopoulos GS et al (2021) Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. Neuropsychopharmacology 46:2235–2240. https://doi.org/10.1038/s41386-021-00978-8
|t Neuropsychopharmacology
|v 46
|y 2021
999 C 5 |a 10.1016/j.eclinm.2021.101044
|1 A Hampshire
|9 -- missing cx lookup --
|2 Crossref
|u Hampshire A, Trender W, Chamberlain SR et al (2021) Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine 39:101044. https://doi.org/10.1016/j.eclinm.2021.101044
|t EClinicalMedicine
|v 39
|y 2021
999 C 5 |a 10.1371/journal.pone.0246590
|1 F Alemanno
|9 -- missing cx lookup --
|2 Crossref
|u Alemanno F, Houdayer E, Parma A et al (2021) COVID-19 cognitive deficits after respiratory assistance in the subacute phase: a COVID-rehabilitation unit experience. PLoS One. https://doi.org/10.1371/journal.pone.0246590
|t PLoS One
|y 2021
999 C 5 |a 10.1016/j.bbih.2020.100163
|1 M Almeria
|9 -- missing cx lookup --
|2 Crossref
|u Almeria M, Cejudo JC, Sotoca J et al (2020) Cognitive profile following COVID-19 infection: clinical predictors leading to neuropsychological impairment. Brain Behav Immun Health 9:100163. https://doi.org/10.1016/j.bbih.2020.100163
|t Brain Behav Immun Health
|v 9
|y 2020
999 C 5 |a 10.1002/acn3.51350
|9 -- missing cx lookup --
|1 EL Graham
|p 1073 -
|2 Crossref
|u Graham EL, Clark JR, Orban ZS et al (2021) Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 “long haulers.” Ann Clin Transl Neurol 8:1073–1085. https://doi.org/10.1002/acn3.51350
|t Ann Clin Transl Neurol
|v 8
|y 2021
999 C 5 |a 10.1186/s13024-021-00469-w
|9 -- missing cx lookup --
|1 Y-H Liu
|p 48 -
|2 Crossref
|u Liu Y-H, Wang Y-R, Wang Q-H et al (2021) Post-infection cognitive impairments in a cohort of elderly patients with COVID-19. Mol Neurodegener 16:48. https://doi.org/10.1186/s13024-021-00469-w
|t Mol Neurodegener
|v 16
|y 2021
999 C 5 |a 10.1093/braincomms/fcaa205
|9 -- missing cx lookup --
|1 MS Woo
|p fcaa205 -
|2 Crossref
|u Woo MS, Malsy J, Pöttgen J et al (2020) Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun 2:fcaa205. https://doi.org/10.1093/braincomms/fcaa205
|t Brain Commun
|v 2
|y 2020
999 C 5 |a 10.1093/braincomms/fcab295
|9 -- missing cx lookup --
|1 S Zhao
|p fcab295 -
|2 Crossref
|u Zhao S, Shibata K, Hellyer PJ et al (2022) Rapid vigilance and episodic memory decrements in COVID-19 survivors. Brain Commun 4:fcab295. https://doi.org/10.1093/braincomms/fcab295
|t Brain Commun
|v 4
|y 2022
999 C 5 |a 10.3389/fneur.2021.699582
|1 R Daroische
|9 -- missing cx lookup --
|2 Crossref
|u Daroische R, Hemminghyth MS, Eilertsen TH et al (2021) Cognitive impairment after COVID-19—a review on objective test data. Front Neurol. https://doi.org/10.3389/fneur.2021.699582
|t Front Neurol
|y 2021
999 C 5 |a 10.1136/bmj.n136
|1 W Shah
|9 -- missing cx lookup --
|2 Crossref
|u Shah W, Hillman T, Playford ED et al (2021) Managing the long term effects of COVID-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. https://doi.org/10.1136/bmj.n136
|t BMJ
|y 2021
999 C 5 |a 10.1016/S1473-3099(21)00703-9
|9 -- missing cx lookup --
|1 JB Soriano
|p e102 -
|2 Crossref
|u Soriano JB, Murthy S, Marshall JC et al (2022) A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 22:e102–e107. https://doi.org/10.1016/S1473-3099(21)00703-9
|t Lancet Infect Dis
|v 22
|y 2022
999 C 5 |a 10.1016/j.lanepe.2021.100122
|1 M Augustin
|9 -- missing cx lookup --
|2 Crossref
|u Augustin M, Schommers P, Stecher M et al (2021) Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Region Health - Europe 6:100122. https://doi.org/10.1016/j.lanepe.2021.100122
|t Lancet Region Health - Europe
|v 6
|y 2021
999 C 5 |a 10.1001/jamanetworkopen.2021.11417
|9 -- missing cx lookup --
|1 T Nasserie
|p e2111417 -
|2 Crossref
|u Nasserie T, Hittle M, Goodman SN (2021) Assessment of the frequency and variety of persistent symptoms among patients with COVID-19. JAMA Netw Open 4:e2111417–e2111417. https://doi.org/10.1001/jamanetworkopen.2021.11417
|t JAMA Netw Open
|v 4
|y 2021
999 C 5 |a 10.1111/j.1532-5415.2005.53221.x
|9 -- missing cx lookup --
|1 ZS Nasreddine
|p 695 -
|2 Crossref
|u Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53(4):695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.x [Erratum in: J Am Geriatr Soc. 2019 Sep;67(9):1991. PMID: 15817019]
|t J Am Geriatr Soc
|v 53
|y 2005
999 C 5 |a 10.1016/0022-3956(75)90026-6
|9 -- missing cx lookup --
|1 MF Folstein
|p 189 -
|2 Crossref
|u Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 12:189–198. https://doi.org/10.1016/0022-3956(75)90026-6
|t J Psychiatric Res
|v 12
|y 1975
999 C 5 |a 10.1176/appi.books.9780890425596
|1 American Psychiatric Association
|y 2013
|2 Crossref
|u American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Publishing, Washington
|9 -- missing cx lookup --
999 C 5 |2 Crossref
|u Herrmann-Lingen C, Buss U and Snaith RP (2018) Hospital Anxiety and Depression Scale (HADS) deutsche version: deutschsprachige adaptation der Hospital and Anxiety and Depression Scale (HADS) von R.P. Snaith und A.S. Zigmond, 4. aktuali. Hogrefe Verlag für Psychologie, Göttingen
999 C 5 |a 10.1001/archneur.1989.00520460115022
|9 -- missing cx lookup --
|1 LB Krupp
|p 1121 -
|2 Crossref
|u Krupp LB (1989) The fatigue severity scale. Arch Neurol 46:1121. https://doi.org/10.1001/archneur.1989.00520460115022
|t Arch Neurol
|v 46
|y 1989
999 C 5 |a 10.1016/0165-1781(89)90047-4
|9 -- missing cx lookup --
|1 DJ Buysse
|p 193 -
|2 Crossref
|u Buysse DJ, Reynolds CF, Monk TH et al (1989) The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213. https://doi.org/10.1016/0165-1781(89)90047-4
|t Psychiatry Res
|v 28
|y 1989
999 C 5 |a 10.1093/sleep/14.6.540
|9 -- missing cx lookup --
|1 MW Johns
|p 540 -
|2 Crossref
|u Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540–545. https://doi.org/10.1093/sleep/14.6.540
|t Sleep
|v 14
|y 1991
999 C 5 |a 10.1007/BF02959944
|9 -- missing cx lookup --
|1 M Bullinger
|p 21 -
|2 Crossref
|u Bullinger M, Kirchberger I, Ware J (1995) Der deutsche SF-36 Health Survey Übersetzung und psychometrische Testung eines krankheitsübergreifenden Instruments zur Erfassung der gesundheitsbezogenen Lebensqualität. J Public Health 3:21–36. https://doi.org/10.1007/BF02959944
|t J Public Health
|v 3
|y 1995
999 C 5 |2 Crossref
|u Sherman RA (2015) multicon: multivariate constructs: R package version 1.6. https://cran.r-project.org/package=multicon
999 C 5 |2 Crossref
|u Foundation for Statistical Computing (2021) R: A language and environment for statistical computing [Computer software]. https://www.r-project.org/
999 C 5 |a 10.1111/j.1600-0404.1995.tb07018.x
|9 -- missing cx lookup --
|1 S Lehrl
|p 335 -
|2 Crossref
|u Lehrl S, Triebig G, Fischer B (1995) Multiple choice vocabulary test MWT as a valid and short test to estimate premorbid intelligence. Acta Neurol Scand 91:335–345. https://doi.org/10.1111/j.1600-0404.1995.tb07018.x
|t Acta Neurol Scand
|v 91
|y 1995
999 C 5 |1 K-H Schmidt
|y 1992
|2 Crossref
|u Schmidt K-H, Metzler P (1992) WST-Wortschatztest. Beltz Test GmbH, Weinheim
|t WST-Wortschatztest
999 C 5 |1 A Chopra
|y 2007
|2 Crossref
|u Chopra A, Cavalieri TA, Libon DJ (2007) Dementia screening tools for the primary care physician. Clin Geriatrics 15:38
999 C 5 |a 10.1038/sj.bjc.6604952
|9 -- missing cx lookup --
|1 S Singer
|p 908 -
|2 Crossref
|u Singer S, Kuhnt S, Götze H et al (2009) Hospital anxiety and depression scale cutoff scores for cancer patients in acute care. Br J Cancer 100:908–912. https://doi.org/10.1038/sj.bjc.6604952
|t Br J Cancer
|v 100
|y 2009
999 C 5 |a 10.1016/j.bbi.2021.12.020
|9 -- missing cx lookup --
|1 F Ceban
|p 93 -
|2 Crossref
|u Ceban F, Ling S, Lui LM et al (2022) Fatigue and cognitive impairment in Post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun 101:93–135. https://doi.org/10.1016/j.bbi.2021.12.020
|t Brain Behav Immun
|v 101
|y 2022
999 C 5 |a 10.1080/23744235.2021.1924397
|9 -- missing cx lookup --
|1 SJ Yong
|p 737 -
|2 Crossref
|u Yong SJ (2021) Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) 53:737–754. https://doi.org/10.1080/23744235.2021.1924397
|t Infect Dis (Lond)
|v 53
|y 2021
999 C 5 |a 10.1007/s00415-021-10579-6
|9 -- missing cx lookup --
|1 F Mattioli
|p 4422 -
|2 Crossref
|u Mattioli F, Stampatori C, Righetti F, Sala E, Tomasi C, De Palma G (2021) Neurological and cognitive sequelae of Covid-19: a four month follow-up. J Neurol 268(12):4422–4428. https://doi.org/10.1007/s00415-021-10579-6
|t J Neurol
|v 268
|y 2021
999 C 5 |a 10.1017/S1092852918001189
|9 -- missing cx lookup --
|1 RS McIntyre
|p 154 -
|2 Crossref
|u McIntyre RS, Anderson N, Baune BT et al (2019) Expert consensus on screening and assessment of cognition in psychiatry. CNS Spectr 24:154–162. https://doi.org/10.1017/S1092852918001189
|t CNS Spectr
|v 24
|y 2019
999 C 5 |a 10.1212/WNL.0b013e3181c34b47
|9 -- missing cx lookup --
|1 S Hoops
|p 1738 -
|2 Crossref
|u Hoops S, Nazem S, Siderowf AD et al (2009) Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 73:1738–1745. https://doi.org/10.1212/WNL.0b013e3181c34b47
|t Neurology
|v 73
|y 2009
999 C 5 |a 10.1001/jama.2021.3331
|9 -- missing cx lookup --
|1 L Morin
|p 1525 -
|2 Crossref
|u Morin L, Savale L, Pham T et al (2021) Four-month clinical status of a cohort of patients after hospitalization for COVID-19. J Am Med Assoc 325:1525–1534. https://doi.org/10.1001/jama.2021.3331
|t J Am Med Assoc
|v 325
|y 2021
999 C 5 |a 10.1111/ene.14803
|9 -- missing cx lookup --
|1 V Rass
|p 3348 -
|2 Crossref
|u Rass V, Beer R, Schiefecker AJ, Kofler M, Lindner A, Mahlknecht P, Heim B, Limmert V, Sahanic S, Pizzini A, Sonnweber T, Tancevski I, Scherfler C, Zamarian L, Bellmann-Weiler R, Weiss G, Djamshidian A, Kiechl S, Seppi K et al (2021) Neurological outcome and quality of life 3 months after COVID-19: A prospective observational cohort study. Eur J Neurol 28(10):3348–3359. https://doi.org/10.1111/ene.14803
|t Eur J Neurol
|v 28
|y 2021
999 C 5 |a 10.1001/jamanetworkopen.2021.30645
|1 JH Becker
|9 -- missing cx lookup --
|2 Crossref
|u Becker JH, Lin JJ, Doernberg M et al (2021) Assessment of cognitive function in patients after COVID-19 infection. JAMA Netw Open. https://doi.org/10.1001/jamanetworkopen.2021.30645
|t JAMA Netw Open
|y 2021
999 C 5 |a 10.3390/brainsci11020235
|9 -- missing cx lookup --
|1 R Ferrucci
|p 235 -
|2 Crossref
|u Ferrucci R, Dini M, Groppo E et al (2021) Long-lasting cognitive abnormalities after COVID-19. Brain Sci 11:235. https://doi.org/10.3390/brainsci11020235
|t Brain Sci
|v 11
|y 2021
999 C 5 |a 10.1093/braincomms/fcac057
|9 -- missing cx lookup --
|1 P Voruz
|p fcac057 -
|2 Crossref
|u Voruz P, Cionca A, Jacot de Alcântara I et al (2022) Functional connectivity underlying cognitive and psychiatric symptoms in post-COVID-19 syndrome: is anosognosia a key determinant? Brain Commun 4:fcac057. https://doi.org/10.1093/braincomms/fcac057
|t Brain Commun
|v 4
|y 2022
999 C 5 |a 10.1002/ana.26262
|9 -- missing cx lookup --
|1 F Schweitzer
|p 150 -
|2 Crossref
|u Schweitzer F, Goereci Y, Franke C et al (2022) Cerebrospinal fluid analysis post-COVID-19 is not suggestive of persistent central nervous system infection. Ann Neurol 91:150–157. https://doi.org/10.1002/ana.26262
|t Ann Neurol
|v 91
|y 2022
999 C 5 |a 10.1186/s12974-021-02339-0
|9 -- missing cx lookup --
|1 S Jarius
|p 19 -
|2 Crossref
|u Jarius S, Pache F, Körtvelyessy P et al (2022) Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients. J Neuroinflamm 19:19. https://doi.org/10.1186/s12974-021-02339-0
|t J Neuroinflamm
|v 19
|y 2022
999 C 5 |a 10.1016/S2215-0366(20)30287-X
|9 -- missing cx lookup --
|1 A Varatharaj
|p 875 -
|2 Crossref
|u Varatharaj A, Thomas N, Ellul MA et al (2020) Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. The Lancet Psychiatry 7:875–882. https://doi.org/10.1016/S2215-0366(20)30287-X
|t The Lancet Psychiatry
|v 7
|y 2020
999 C 5 |a 10.1056/NEJMcibr2113694
|9 -- missing cx lookup --
|1 WJ Murphy
|p 394 -
|2 Crossref
|u Murphy WJ, Longo DL (2022) A possible role for anti-idiotype antibodies in SARS-CoV-2 infection and vaccination. N Engl J Med 386:394–396. https://doi.org/10.1056/NEJMcibr2113694
|t N Engl J Med
|v 386
|y 2022
999 C 5 |a 10.23668/psycharchives.8221
|1 D Scharfenberg
|9 -- missing cx lookup --
|2 Crossref
|u Scharfenberg D, Schild A-K, Warnke C, Maier F (2022) A network perspective on neuropsychiatric and cognitive symptoms of the post-COVID syndrome. Eur J Psychol. https://doi.org/10.23668/psycharchives.8221
|t Eur J Psychol
|y 2022
999 C 5 |a 10.1016/j.euroneuro.2021.03.019
|9 -- missing cx lookup --
|1 KW Miskowiak
|p 39 -
|2 Crossref
|u Miskowiak KW, Johnsen S, Sattler SM et al (2021) Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables. Eur Neuropsychopharmacol 46:39–48. https://doi.org/10.1016/j.euroneuro.2021.03.019
|t Eur Neuropsychopharmacol
|v 46
|y 2021
999 C 5 |a 10.1001/jamainternmed.2021.6454
|9 -- missing cx lookup --
|1 J Matta
|p 19 -
|2 Crossref
|u Matta J, Wiernik E, Robineau O et al (2022) Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among french adults during the COVID-19 pandemic. JAMA Intern Med 182:19–25. https://doi.org/10.1001/jamainternmed.2021.6454
|t JAMA Intern Med
|v 182
|y 2022
999 C 5 |a 10.1080/21641846.2021.1922140
|9 -- missing cx lookup --
|1 LA Jason
|p 59 -
|2 Crossref
|u Jason LA, Islam M, Conroy K et al (2021) COVID-19 symptoms over time: comparing long-haulers to ME/CFS. Fatigue 9:59–68. https://doi.org/10.1080/21641846.2021.1922140
|t Fatigue
|v 9
|y 2021
999 C 5 |a 10.1101/2021.06.11.21258690
|1 G Douaud
|9 -- missing cx lookup --
|2 Crossref
|u Douaud G, Lee S, Alfaro-Almagro F et al (2022) SARS-CoV-2 is associated with changes in brain structure in UK Biobank. medRxiv. https://doi.org/10.1101/2021.06.11.21258690
|t medRxiv
|y 2022
999 C 5 |a 10.1016/j.bbi.2020.12.022
|9 -- missing cx lookup --
|1 C Franke
|p 415 -
|2 Crossref
|u Franke C, Ferse C, Kreye J et al (2021) High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms. Brain Behav Immun 93:415–419. https://doi.org/10.1016/j.bbi.2020.12.022
|t Brain Behav Immun
|v 93
|y 2021
999 C 5 |a 10.1371/journal.pmed.1003773
|1 M Taquet
|9 -- missing cx lookup --
|2 Crossref
|u Taquet M, Dercon Q, Luciano S et al (2021) Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. https://doi.org/10.1371/journal.pmed.1003773
|t PLoS Med
|y 2021
999 C 5 |a 10.1016/j.bbih.2022.100425
|1 A Costas-Carrera
|9 -- missing cx lookup --
|2 Crossref
|u Costas-Carrera A, Sánchez-Rodríguez MM, Cañizares S et al (2022) Neuropsychological functioning in post-ICU patients after severe COVID-19 infection: the role of cognitive reserve. Brain Behav Immun Health 21:100425. https://doi.org/10.1016/j.bbih.2022.100425
|t Brain Behav Immun Health
|v 21
|y 2022
999 C 5 |a 10.1007/s00415-020-10067-3
|9 -- missing cx lookup --
|1 X Chen
|p 392 -
|2 Crossref
|u Chen X, Laurent S, Onur OA et al (2021) A systematic review of neurological symptoms and complications of COVID-19. J Neurol 268:392–402. https://doi.org/10.1007/s00415-020-10067-3
|t J Neurol
|v 268
|y 2021


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21